Agenus Inc. (AGEN)
USD 1.5
(-6.25%)
USD 1.5
(-6.25%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 462.29 Million USD | -1.32% |
| 2022 | 468.45 Million USD | 12.06% |
| 2021 | 418.04 Million USD | -1.87% |
| 2020 | 426.01 Million USD | 10.17% |
| 2019 | 386.67 Million USD | 24.35% |
| 2018 | 310.94 Million USD | 45.15% |
| 2017 | 214.21 Million USD | 9.23% |
| 2016 | 196.11 Million USD | 14.35% |
| 2015 | 171.5 Million USD | 232.95% |
| 2014 | 51.5 Million USD | 31.01% |
| 2013 | 39.31 Million USD | -15.8% |
| 2012 | 46.69 Million USD | 14.9% |
| 2011 | 40.63 Million USD | -10.91% |
| 2010 | 45.61 Million USD | -27.42% |
| 2009 | 62.84 Million USD | -22.28% |
| 2008 | 80.86 Million USD | -11.72% |
| 2007 | 91.59 Million USD | 1.39% |
| 2006 | 90.34 Million USD | 25.04% |
| 2005 | 72.25 Million USD | 171.47% |
| 2004 | 26.61 Million USD | -23.6% |
| 2003 | 34.83 Million USD | 208.11% |
| 2002 | 11.3 Million USD | -35.84% |
| 2001 | 17.62 Million USD | 56.46% |
| 2000 | 11.26 Million USD | 161.91% |
| 1999 | 4.3 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 513.25 Million USD | 14.85% |
| 2024 Q1 | 446.88 Million USD | -3.33% |
| 2023 Q2 | 460.35 Million USD | -1.2% |
| 2023 Q1 | 465.96 Million USD | -0.53% |
| 2023 FY | 462.29 Million USD | -1.32% |
| 2023 Q3 | 450.76 Million USD | -2.08% |
| 2023 Q4 | 462.29 Million USD | 2.56% |
| 2022 FY | 468.45 Million USD | 12.06% |
| 2022 Q4 | 468.45 Million USD | 6.26% |
| 2022 Q3 | 440.85 Million USD | -0.38% |
| 2022 Q2 | 442.53 Million USD | 6.98% |
| 2022 Q1 | 413.65 Million USD | -1.05% |
| 2021 Q2 | 448.05 Million USD | 3.51% |
| 2021 Q1 | 432.86 Million USD | 1.61% |
| 2021 FY | 418.04 Million USD | -1.87% |
| 2021 Q3 | 402.08 Million USD | -10.26% |
| 2021 Q4 | 418.04 Million USD | 3.97% |
| 2020 Q4 | 426.01 Million USD | 3.7% |
| 2020 Q1 | 382.55 Million USD | -1.06% |
| 2020 Q2 | 411.74 Million USD | 7.63% |
| 2020 FY | 426.01 Million USD | 10.17% |
| 2020 Q3 | 410.8 Million USD | -0.23% |
| 2019 Q2 | 368.31 Million USD | 0.85% |
| 2019 Q3 | 379.67 Million USD | 3.08% |
| 2019 FY | 386.67 Million USD | 24.35% |
| 2019 Q4 | 386.67 Million USD | 1.84% |
| 2019 Q1 | 365.21 Million USD | 17.45% |
| 2018 FY | 310.94 Million USD | 45.15% |
| 2018 Q2 | 245.02 Million USD | 0.4% |
| 2018 Q4 | 310.94 Million USD | 18.74% |
| 2018 Q3 | 261.86 Million USD | 6.87% |
| 2018 Q1 | 244.04 Million USD | 13.93% |
| 2017 Q2 | 193.97 Million USD | -0.2% |
| 2017 Q4 | 214.21 Million USD | 6.65% |
| 2017 FY | 214.21 Million USD | 9.23% |
| 2017 Q1 | 194.36 Million USD | -0.89% |
| 2017 Q3 | 200.86 Million USD | 3.55% |
| 2016 Q3 | 195.88 Million USD | 9.08% |
| 2016 Q2 | 179.57 Million USD | 1.64% |
| 2016 Q1 | 176.68 Million USD | 3.02% |
| 2016 FY | 196.11 Million USD | 14.35% |
| 2016 Q4 | 196.11 Million USD | 0.12% |
| 2015 FY | 171.5 Million USD | 232.95% |
| 2015 Q1 | 71.06 Million USD | 37.97% |
| 2015 Q4 | 171.5 Million USD | 3.54% |
| 2015 Q3 | 165.63 Million USD | 78.25% |
| 2015 Q2 | 92.92 Million USD | 30.75% |
| 2014 Q2 | 42.55 Million USD | -5.47% |
| 2014 Q1 | 45.01 Million USD | 14.51% |
| 2014 FY | 51.5 Million USD | 31.01% |
| 2014 Q3 | 38.76 Million USD | -8.91% |
| 2014 Q4 | 51.5 Million USD | 32.89% |
| 2013 Q4 | 39.31 Million USD | -3.04% |
| 2013 FY | 39.31 Million USD | -15.8% |
| 2013 Q2 | 38.63 Million USD | -19.2% |
| 2013 Q1 | 47.81 Million USD | 2.41% |
| 2013 Q3 | 40.54 Million USD | 4.95% |
| 2012 Q1 | 43.83 Million USD | 7.87% |
| 2012 Q4 | 46.69 Million USD | 2.89% |
| 2012 FY | 46.69 Million USD | 14.9% |
| 2012 Q3 | 45.38 Million USD | 1.69% |
| 2012 Q2 | 44.62 Million USD | 1.8% |
| 2011 FY | 40.63 Million USD | -10.91% |
| 2011 Q4 | 40.63 Million USD | 0.49% |
| 2011 Q3 | 40.43 Million USD | 2.68% |
| 2011 Q2 | 39.38 Million USD | 1.28% |
| 2011 Q1 | 38.88 Million USD | -14.75% |
| 2010 Q3 | 61.69 Million USD | -0.25% |
| 2010 Q1 | 63.52 Million USD | 1.08% |
| 2010 Q2 | 61.84 Million USD | -2.64% |
| 2010 Q4 | 45.61 Million USD | -26.07% |
| 2010 FY | 45.61 Million USD | -27.42% |
| 2009 Q2 | 68.26 Million USD | -11.81% |
| 2009 Q3 | 70.26 Million USD | 2.92% |
| 2009 Q4 | 62.84 Million USD | -10.55% |
| 2009 FY | 62.84 Million USD | -22.28% |
| 2009 Q1 | 77.4 Million USD | -4.27% |
| 2008 FY | 80.86 Million USD | -11.72% |
| 2008 Q4 | 80.86 Million USD | -12.48% |
| 2008 Q3 | 92.39 Million USD | 0.35% |
| 2008 Q2 | 92.06 Million USD | 1.45% |
| 2008 Q1 | 90.75 Million USD | -0.92% |
| 2007 Q3 | 92.13 Million USD | 2.66% |
| 2007 FY | 91.59 Million USD | 1.39% |
| 2007 Q1 | 88.15 Million USD | -2.42% |
| 2007 Q4 | 91.59 Million USD | -0.58% |
| 2007 Q2 | 89.74 Million USD | 1.8% |
| 2006 FY | 90.34 Million USD | 25.04% |
| 2006 Q4 | 90.34 Million USD | 35.54% |
| 2006 Q3 | 66.65 Million USD | 0.86% |
| 2006 Q2 | 66.08 Million USD | -2.73% |
| 2006 Q1 | 67.93 Million USD | -5.97% |
| 2005 Q1 | 73.8 Million USD | 177.32% |
| 2005 Q4 | 72.25 Million USD | 0.46% |
| 2005 Q2 | 75.57 Million USD | 2.39% |
| 2005 FY | 72.25 Million USD | 171.47% |
| 2005 Q3 | 71.92 Million USD | -4.83% |
| 2004 Q2 | 28.64 Million USD | -26.34% |
| 2004 FY | 26.61 Million USD | -23.6% |
| 2004 Q3 | 28.79 Million USD | 0.52% |
| 2004 Q4 | 26.61 Million USD | -7.57% |
| 2004 Q1 | 38.88 Million USD | 11.64% |
| 2003 Q3 | 29.42 Million USD | 124.07% |
| 2003 Q1 | 11.36 Million USD | 0.52% |
| 2003 FY | 34.83 Million USD | 208.11% |
| 2003 Q4 | 34.83 Million USD | 18.37% |
| 2003 Q2 | 13.13 Million USD | 15.56% |
| 2002 Q4 | 11.3 Million USD | 4.81% |
| 2002 Q1 | 15.86 Million USD | -9.94% |
| 2002 Q2 | 11.12 Million USD | -29.89% |
| 2002 Q3 | 10.78 Million USD | -3.04% |
| 2002 FY | 11.3 Million USD | -35.84% |
| 2001 Q1 | 9.08 Million USD | -19.35% |
| 2001 Q2 | 9.27 Million USD | 2.12% |
| 2001 FY | 17.62 Million USD | 56.46% |
| 2001 Q4 | 17.62 Million USD | 7.5% |
| 2001 Q3 | 16.39 Million USD | 76.72% |
| 2000 Q2 | 4.48 Million USD | -1.18% |
| 2000 FY | 11.26 Million USD | 161.91% |
| 2000 Q3 | 5.41 Million USD | 20.92% |
| 2000 Q4 | 11.26 Million USD | 107.89% |
| 2000 Q1 | 4.53 Million USD | 0.0% |
| 1999 FY | 4.3 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -37.68% |
| Alkermes plc | 933.53 Million USD | 50.479% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 88.587% |
| Aptorum Group Limited | 5.25 Million USD | -8694.332% |
| Ardelyx, Inc. | 130.76 Million USD | -253.537% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 3.364% |
| Bicycle Therapeutics plc | 224.41 Million USD | -106.003% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -255.038% |
| ChromaDex Corporation | 26.5 Million USD | -1643.983% |
| Chimerix, Inc. | 19.74 Million USD | -2241.327% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1214.192% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -537.06% |
| CRISPR Therapeutics AG | 346.76 Million USD | -33.315% |
| Precision BioSciences, Inc. | 140.92 Million USD | -228.055% |
| Dyadic International, Inc. | 2.34 Million USD | -19650.702% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2742.618% |
| Fortress Biotech, Inc. | 165.93 Million USD | -178.593% |
| Lantern Pharma Inc. | 2.73 Million USD | -16774.039% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -546.747% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -13000.908% |
| Incyte Corporation | 1.59 Billion USD | 70.966% |
| IO Biotech, Inc. | 17.55 Million USD | -2533.259% |
| Jaguar Health, Inc. | 45.86 Million USD | -907.925% |
| Novavax, Inc. | 2.57 Billion USD | 82.028% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1182.087% |
| Opthea Limited | 264.6 Million USD | -74.714% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -253.688% |
| ContextLogic Inc. | 206 Million USD | -124.415% |
| MiMedx Group, Inc. | 96.33 Million USD | -379.908% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -862.673% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -13000.306% |
| NextCure, Inc. | 14.99 Million USD | -2982.583% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -11337.284% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -6823.693% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -889.099% |
| Vaxcyte, Inc. | 167.44 Million USD | -176.081% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1289.979% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -96.542% |
| Pharming Group N.V. | 244.07 Million USD | -89.408% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3777.663% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -261.759% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -6896.753% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -6896.753% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -460.813% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -6859.13% |
| Acelyrin, Inc. | 86.35 Million USD | -435.355% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -35481.928% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -3115.071% |
| Summit Therapeutics Inc. | 125.25 Million USD | -269.077% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -4777.044% |
| Senti Biosciences, Inc. | 52.57 Million USD | -779.373% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -572.165% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -205.121% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -23534.714% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -34514.215% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -103.805% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -4835.358% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -103.256% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 6.514% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -4135.798% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1580.401% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3719.137% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 4.995% |
| Immix Biopharma, Inc. | 3.72 Million USD | -12321.331% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -1122.615% |
| MEI Pharma, Inc. | 8.35 Million USD | -5433.154% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1493.297% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -33.004% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -216.925% |
| Fortress Biotech, Inc. | 165.93 Million USD | -178.593% |
| Precigen, Inc. | 41.64 Million USD | -1010.112% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -825.886% |
| AlloVir, Inc. | 45.01 Million USD | -926.98% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -254.692% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -235.483% |
| ImmuCell Corporation | 18.81 Million USD | -2357.052% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1537.834% |
| Onconetix, Inc. | 23.18 Million USD | -1894.294% |
| PureTech Health plc | 125.58 Million USD | -268.119% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -5065.307% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1248.507% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -18807.771% |
| Seer, Inc. | 39.36 Million USD | -1074.381% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -647.639% |
| Innoviva, Inc. | 568.55 Million USD | 18.689% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1597.866% |
| ESSA Pharma Inc. | 3.49 Million USD | -13127.056% |
| GlycoMimetics, Inc. | 6.9 Million USD | -6597.914% |
| GT Biopharma, Inc. | 6.63 Million USD | -6869.622% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -74.853% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -69.782% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -450.181% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -4629.844% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1601.553% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -14231.294% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -526.696% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2824.307% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -4087.574% |
| Soligenix, Inc. | 7.27 Million USD | -6254.654% |
| Century Therapeutics, Inc. | 175.94 Million USD | -162.756% |
| Kura Oncology, Inc. | 51.66 Million USD | -794.845% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -281.174% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -11085.459% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -6889.796% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -83.016% |
| Autolus Therapeutics plc | 263.9 Million USD | -75.173% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -4310.37% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -420.245% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -885.725% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -31.015% |
| GRI Bio, Inc. | 2.69 Million USD | -17041.083% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -57002.713% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1386.909% |
| IGM Biosciences, Inc. | 220.17 Million USD | -109.965% |
| INmune Bio, Inc. | 18.86 Million USD | -2350.933% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -80.247% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1635.224% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -16906.106% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -13993.217% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -690.856% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -380.761% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -74.626% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 43.83% |
| Verastem, Inc. | 71.18 Million USD | -549.428% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -840.083% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -1098.338% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -844.77% |
| Histogen Inc. | 5.69 Million USD | -8014.709% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -10441.191% |
| Surrozen, Inc. | 8.14 Million USD | -5575.813% |
| Organovo Holdings, Inc. | 2.74 Million USD | -16722.962% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -147194.318% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -722.152% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2699.752% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -804.634% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -55808.692% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -264.802% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -4175.13% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -206.381% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -17630.488% |
| Apollomics, Inc. | 14.15 Million USD | -3166.41% |
| Amarin Corporation plc | 279.58 Million USD | -65.349% |
| Mesoblast Limited | 188.79 Million USD | -144.862% |
| Turnstone Biologics Corp. | 14.14 Million USD | -3167.564% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -155.711% |
| Synaptogenix, Inc. | 5.52 Million USD | -8260.568% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -6853.896% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -171.766% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5302.414% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -26205.727% |
| Exelixis, Inc. | 678.44 Million USD | 31.86% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1838.994% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -181.808% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 22.2% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4228.522% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -28373.173% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -1087.595% |
| Gritstone bio, Inc. | 125.91 Million USD | -267.137% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3050.007% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -8984.867% |
| Avid Bioservices, Inc. | 275.66 Million USD | -67.7% |
| Insmed Incorporated | 1.66 Billion USD | 72.18% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -5908.494% |
| MediWound Ltd. | 27.18 Million USD | -1600.427% |
| OmniAb, Inc. | 87.4 Million USD | -428.942% |
| Alector, Inc. | 487.66 Million USD | 5.203% |
| Seres Therapeutics, Inc. | 403.45 Million USD | -14.584% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2409.064% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -1104.74% |
| Zai Lab Limited | 240.17 Million USD | -92.481% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 26.627% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1481.739% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -386.232% |
| Immunic, Inc. | 25.36 Million USD | -1722.355% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -567.709% |
| Veracyte, Inc. | 93.71 Million USD | -393.278% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -17567.282% |
| FibroGen, Inc. | 585.72 Million USD | 21.073% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2559.466% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -70687.32% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -8074.316% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 93.962% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -5539.119% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -450.207% |
| TG Therapeutics, Inc. | 169.08 Million USD | -173.41% |
| Galecto, Inc. | 5.89 Million USD | -7740.824% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -5480.577% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 82.344% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1503.966% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3562.903% |
| XBiotech Inc. | 8.39 Million USD | -5405.478% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -3050.007% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -769.302% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -27.317% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1619.592% |
| Theravance Biopharma, Inc. | 169 Million USD | -173.541% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 61.97% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 7.62% |
| Vaxxinity, Inc. | 30.94 Million USD | -1393.973% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 52.463% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -7565.177% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 37.966% |
| NexImmune, Inc. | 5.08 Million USD | -8992.72% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -124375.624% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -14934.727% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 93.495% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -8869.583% |
| Scopus BioPharma Inc. | 7.45 Million USD | -6101.611% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1658.177% |
| Ainos, Inc. | 7.39 Million USD | -6152.111% |
| Pluri Inc. | 34.11 Million USD | -1255.227% |
| Prothena Corporation plc | 135.01 Million USD | -242.398% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -90.164% |
| Celularity Inc. | 102.92 Million USD | -349.14% |
| Rallybio Corporation | 9.43 Million USD | -4799.269% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1791.164% |
| MeiraGTx Holdings plc | 319.99 Million USD | -44.471% |
| Omeros Corporation | 403.25 Million USD | -14.642% |
| Humacyte, Inc. | 114.67 Million USD | -303.128% |
| Immunocore Holdings plc | 228.15 Million USD | -102.621% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -9382.974% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -502.417% |
| Blueprint Medicines Corporation | 918.64 Million USD | 49.676% |
| CalciMedica, Inc. | 4.02 Million USD | -11377.036% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2548.951% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -199.913% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -438.699% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -66.417% |
| Pulmatrix, Inc. | 15.96 Million USD | -2796.041% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2830.926% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1778.79% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -84.322% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -810.28% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 61.814% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1354.535% |
| Nutriband Inc. | 1.07 Million USD | -42747.98% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -4247.738% |
| Vor Biopharma Inc. | 59.1 Million USD | -682.172% |
| Roivant Sciences Ltd. | 773.95 Million USD | 40.268% |
| Evogene Ltd. | 17.99 Million USD | -2469.733% |
| ProKidney Corp. | 29.21 Million USD | -1482.335% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -542.264% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -65475.34% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 75.526% |
| CorMedix Inc. | 11.91 Million USD | -3779.118% |
| BioLineRx Ltd. | 50.7 Million USD | -811.788% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -209.312% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -422.716% |
| Atai Life Sciences N.V. | 49.16 Million USD | -840.35% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1383.983% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2473.739% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -270.916% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -8076.424% |
| MediciNova, Inc. | 3.89 Million USD | -11779.448% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2429.104% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -30632.775% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13033.825% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -16.371% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1406.338% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 83.015% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2796.222% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1381.667% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -687.77% |
| Absci Corporation | 58.3 Million USD | -692.904% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2327.0% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1341.878% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -526.501% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -428.44% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1268.952% |
| Allakos Inc. | 74.79 Million USD | -518.099% |
| Imunon, Inc. | 8.53 Million USD | -5319.365% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1954.553% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -302.654% |
| BioAtla, Inc. | 48.98 Million USD | -843.729% |
| NLS Pharmaceutics AG | 10.68 Million USD | -4228.522% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -16535.3% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -253.967% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -3152.163% |
| XOMA Corporation | 145.58 Million USD | -217.554% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1273.221% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -572.341% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1363.098% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -647.772% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -928.122% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -855.115% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -16007.84% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -5566.756% |
| Akari Therapeutics, Plc | 4.58 Million USD | -9984.969% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2506.957% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 71.973% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -114355.52% |
| UroGen Pharma Ltd. | 243.52 Million USD | -89.836% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -43.978% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -16640.369% |
| Orgenesis Inc. | 35.53 Million USD | -1200.957% |
| Entera Bio Ltd. | 1.37 Million USD | -33423.93% |
| GH Research PLC | 6.7 Million USD | -6798.896% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -6698.456% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2355.62% |
| Xencor, Inc. | 283.55 Million USD | -63.033% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -15383.768% |
| Replimune Group, Inc. | 113.21 Million USD | -308.337% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -12204.488% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -346.532% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -114355.52% |
| Portage Biotech Inc. | 4.45 Million USD | -10288.652% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -30632.775% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1905.618% |
| OncoCyte Corporation | 49.29 Million USD | -837.756% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -11075.17% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -57869.188% |
| Purple Biotech Ltd. | 10 Million USD | -4520.64% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -7889.889% |
| scPharmaceuticals Inc. | 57.26 Million USD | -707.347% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3631.791% |
| HilleVax, Inc. | 78.9 Million USD | -485.858% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -9054.356% |
| Tharimmune, Inc. | 1.81 Million USD | -25370.153% |
| Genprex, Inc. | 3.25 Million USD | -14106.068% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1604.69% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -8729.163% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -224315.049% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -128835.317% |
| OKYO Pharma Limited | 7.42 Million USD | -6129.681% |
| Savara Inc. | 37.19 Million USD | -1142.996% |
| Curis, Inc. | 57.61 Million USD | -702.428% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1655.783% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -1079.33% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -31914.889% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -2120.544% |
| BeiGene, Ltd. | 2.23 Billion USD | 79.304% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -2071.439% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -76.182% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -2073.052% |
| Erasca, Inc. | 78.61 Million USD | -488.079% |
| bluebird bio, Inc. | 424.62 Million USD | -8.872% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -70452.246% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 75.541% |
| DBV Technologies S.A. | 42.8 Million USD | -980.129% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -70452.246% |
| Moderna, Inc. | 4.57 Billion USD | 89.889% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -6508.935% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -27816.365% |
| Molecular Templates, Inc. | 31.17 Million USD | -1383.093% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2608.231% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 21.392% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -271.306% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1584.933% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1168.09% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -730.943% |
| MacroGenics, Inc. | 154.2 Million USD | -199.789% |
| RenovoRx, Inc. | 4.46 Million USD | -10251.433% |
| Adicet Bio, Inc. | 37.12 Million USD | -1145.407% |
| Prime Medicine, Inc. | 60.78 Million USD | -660.604% |
| Aditxt, Inc. | 28.53 Million USD | -1520.294% |
| Adagene Inc. | 45.16 Million USD | -923.471% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -255734.223% |
| Quantum-Si incorporated | 26.63 Million USD | -1635.928% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 33.727% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -15094.886% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -302.132% |
| SciSparc Ltd. | 1.59 Million USD | -28884.013% |
| Vericel Corporation | 127.7 Million USD | -262.002% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8207.346% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -441.595% |
| Generation Bio Co. | 171.63 Million USD | -169.356% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3902.554% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -1005.149% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -82.944% |
| Invivyd, Inc. | 51.71 Million USD | -793.963% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -402.62% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -7006.49% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -512.344% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -45178.648% |
| 2seventy bio, Inc. | 310.12 Million USD | -49.067% |
| ADMA Biologics, Inc. | 193.97 Million USD | -138.326% |
| Clene Inc. | 38.95 Million USD | -1086.863% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1179.431% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -79.898% |
| GeoVax Labs, Inc. | 3.51 Million USD | -13033.825% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -142.977% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3695.631% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -133.103% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3690.919% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -860.893% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -774.879% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -24.994% |
| Evaxion Biotech A/S | 17.61 Million USD | -2524.07% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -187.266% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -201.787% |
| Trevena, Inc. | 48.26 Million USD | -857.886% |
| Surrozen, Inc. | 8.14 Million USD | -5575.813% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -2040.75% |
| Cingulate Inc. | 10.36 Million USD | -4361.934% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -16710.727% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -1139.663% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -12789.793% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -3415.551% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -45.742% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1760.417% |
| Clearmind Medicine Inc. | 3.61 Million USD | -12705.927% |
| Kronos Bio, Inc. | 54.2 Million USD | -752.927% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -882.707% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1931.197% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -2203.298% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1938.657% |
| ImmunityBio, Inc. | 1.09 Billion USD | 57.603% |
| Korro Bio, Inc. | 51.75 Million USD | -793.289% |
| Kineta, Inc. | 7.22 Million USD | -6301.205% |
| BioVie Inc. | 9.7 Million USD | -4664.882% |
| Codexis, Inc. | 49.94 Million USD | -825.59% |
| Celularity Inc. | 102.92 Million USD | -349.14% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -380.321% |
| Celcuity Inc. | 51.45 Million USD | -798.531% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -133823.243% |
| Cibus, Inc. | 206.11 Million USD | -124.288% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -988.393% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1655.173% |
| IN8bio, Inc. | 8.77 Million USD | -5170.121% |
| Kodiak Sciences Inc. | 213.59 Million USD | -116.439% |
| Annexon, Inc. | 47.11 Million USD | -881.143% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -416.294% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -379.698% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -3277.128% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 82.243% |
| Eyenovia, Inc. | 19.78 Million USD | -2237.151% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -161.057% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5918.682% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1818.316% |
| Arcellx, Inc. | 339.75 Million USD | -36.068% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3785.485% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -88.277% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4734.205% |
| Moolec Science SA | 13.94 Million USD | -3215.046% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -971.318% |
| Geron Corporation | 146.12 Million USD | -216.365% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -814.856% |
| Royalty Pharma plc | 6.29 Billion USD | 92.659% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -1062.246% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -156926.351% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -18690.326% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -144.399% |
| Humacyte, Inc. | 114.67 Million USD | -303.128% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1491.322% |
| 89bio, Inc. | 59.96 Million USD | -670.967% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1646.949% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -38553.428% |
| Genelux Corporation | 8.42 Million USD | -5390.439% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -6642.926% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -239.127% |
| Notable Labs, Ltd. | 4.42 Million USD | -10342.625% |
| Liquidia Corporation | 73.13 Million USD | -532.086% |
| Mustang Bio, Inc. | 17.61 Million USD | -2523.844% |
| Immunovant, Inc. | 48.95 Million USD | -844.326% |
| Quantum-Si incorporated | 26.63 Million USD | -1635.928% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -1104.426% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -14798.324% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -525.899% |
| Acasti Pharma Inc. | 11.55 Million USD | -3900.13% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1944.854% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -16906.106% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -1153.613% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -33821.394% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -7483.579% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1761.466% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1894.026% |
| PepGen Inc. | 34.63 Million USD | -1234.917% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3706.777% |
| United Therapeutics Corporation | 1.18 Billion USD | 60.895% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -6519.344% |
| Solid Biosciences Inc. | 38.45 Million USD | -1102.078% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -5302.414% |
| Immuneering Corporation | 12 Million USD | -3749.778% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -147194.318% |
| Silo Pharma, Inc. | 1.56 Million USD | -29359.239% |
| Belite Bio, Inc | 4.21 Million USD | -10878.271% |
| XOMA Corporation | 145.58 Million USD | -217.554% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -18940.157% |
| Bionomics Limited | 10.15 Million USD | -4450.721% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -2051.11% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1917.61% |
| uniQure N.V. | 624.01 Million USD | 25.917% |
| Cassava Sciences, Inc. | 14.19 Million USD | -3156.745% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -255734.223% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -171.644% |
| Forte Biosciences, Inc. | 3.66 Million USD | -12510.338% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -177307.966% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -6751.86% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5918.682% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2559.466% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -4274.48% |
| Altimmune, Inc. | 16.54 Million USD | -2694.843% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 25.159% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1917.61% |
| Compugen Ltd. | 55.77 Million USD | -728.857% |
| Peak Bio, Inc. | 20.75 Million USD | -2127.567% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -318.507% |
| Benitec Biopharma Inc. | 4.96 Million USD | -9216.707% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -192.883% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -514.967% |
| Zura Bio Limited | 21.29 Million USD | -2071.215% |
| PolyPid Ltd. | 17.46 Million USD | -2546.525% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -311.298% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -514.967% |
| Instil Bio, Inc. | 99.8 Million USD | -363.217% |
| argenx SE | 444.95 Million USD | -3.898% |
| Immunome, Inc. | 28.65 Million USD | -1513.145% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -5445.1% |
| Verona Pharma plc | 58.84 Million USD | -685.668% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -3094.189% |
| Shattuck Labs, Inc. | 14.85 Million USD | -3011.212% |
| CervoMed Inc. | 2.59 Million USD | -17709.709% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -9384.92% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3529.829% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -4288.182% |
| Moolec Science SA | 13.94 Million USD | -3215.046% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -19626.657% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -731.536% |
| AnaptysBio, Inc. | 364.28 Million USD | -26.904% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3766.636% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3544.71% |
| NeurAxis, Inc. | 1.91 Million USD | -24069.267% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -1087.564% |
| Lumos Pharma, Inc. | 13.33 Million USD | -3367.299% |
| Achilles Therapeutics plc | 19.08 Million USD | -2322.041% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -3094.189% |
| 180 Life Sciences Corp. | 5.38 Million USD | -8481.345% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1859.874% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1931.197% |
| Nutriband Inc. | 1.07 Million USD | -42747.98% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1410.867% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -3085.825% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -15.207% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1323.629% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -3442.736% |
| Palisade Bio, Inc. | 2.73 Million USD | -16778.24% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -8700.59% |
| Beam Therapeutics Inc. | 478.38 Million USD | 3.363% |
| Neurogene Inc. | 36.54 Million USD | -1164.864% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -16.169% |
| AEON Biopharma, Inc. | 159.88 Million USD | -189.135% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -870.189% |
| Sesen Bio, Inc. | 30.98 Million USD | -1392.044% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1680.729% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -5981.056% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -136.181% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -140.707% |
| Athira Pharma, Inc. | 30.05 Million USD | -1438.061% |
| Vaccinex, Inc. | 5.94 Million USD | -7680.125% |
| HCW Biologics Inc. | 15.05 Million USD | -2971.331% |
| XOMA Corporation | 145.58 Million USD | -217.554% |
| Nektar Therapeutics | 267.04 Million USD | -73.114% |
| Arvinas, Inc. | 644.6 Million USD | 28.282% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2506.957% |
| Merus N.V. | 102.15 Million USD | -352.56% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -215.883% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -386.012% |
| Rezolute, Inc. | 11.73 Million USD | -3839.79% |
| Clene Inc. | 38.95 Million USD | -1086.863% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -16135.803% |
| BeyondSpring Inc. | 48.26 Million USD | -857.747% |
| Synlogic, Inc. | 32.89 Million USD | -1305.366% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -3063.587% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -28192.228% |
| Peak Bio, Inc. | 20.75 Million USD | -2127.567% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -628.494% |
| Krystal Biotech, Inc. | 39.71 Million USD | -1064.061% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -22.741% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -364.296% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -106733.192% |
| MannKind Corporation | 721.36 Million USD | 35.914% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1969.823% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -22061.793% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -350.624% |
| Gossamer Bio, Inc. | 249.14 Million USD | -85.551% |
| CohBar, Inc. | 1.03 Million USD | -44625.039% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -4224.96% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2327.0% |
| Legend Biotech Corporation | 589.93 Million USD | 21.636% |
| Mural Oncology plc | 37.92 Million USD | -1118.875% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -248.544% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -20040.659% |
| Disc Medicine, Inc. | 22.87 Million USD | -1920.962% |
| Champions Oncology, Inc. | 28.03 Million USD | -1548.992% |
| REGENXBIO Inc. | 262.22 Million USD | -76.295% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -13661.434% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3588.328% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -3341.839% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -2080.123% |
| Vaxart, Inc. | 34.02 Million USD | -1258.692% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -2167.345% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1520.275% |
| Cellectis S.A. | 249.57 Million USD | -85.233% |
| Longeveron Inc. | 5.33 Million USD | -8562.076% |
| Repare Therapeutics Inc. | 41.81 Million USD | -1005.466% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 80.78% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -665.795% |
| Revolution Medicines, Inc. | 262.39 Million USD | -76.182% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -21840.911% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -5259.321% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3817.422% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -3191.996% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -21392.097% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 91.023% |
| Denali Therapeutics Inc. | 122.96 Million USD | -275.963% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -8207.346% |
| Veru Inc. | 32.81 Million USD | -1308.89% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -6630.165% |
| Cingulate Inc. | 10.36 Million USD | -4361.934% |
| Passage Bio, Inc. | 39.26 Million USD | -1077.462% |
| Context Therapeutics Inc. | 4.19 Million USD | -10928.779% |
| Exicure, Inc. | 8.54 Million USD | -5307.592% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1466.677% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -4308.688% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1997.432% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -183.641% |
| Nuvalent, Inc. | 31.82 Million USD | -1352.707% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -7166.93% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -633.545% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2468.306% |
| OmniAb, Inc. | 87.4 Million USD | -428.942% |
| Anew Medical, Inc. | 8.24 Million USD | -5509.152% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -1107.38% |
| Lipocine Inc. | 2.63 Million USD | -17466.876% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1659.649% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -1049.644% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1635.224% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -436.591% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -8459.433% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -458.685% |
| Ocugen, Inc. | 23.98 Million USD | -1827.595% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -896.175% |
| Q32 Bio Inc. | 233.12 Million USD | -98.301% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -4999.217% |
| Alumis Inc. Common Stock | 53.5 Million USD | -764.071% |
| Equillium, Inc. | 27.95 Million USD | -1553.593% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -123.772% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -8116.146% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -7437.867% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -193.845% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -565.815% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -4534.908% |
| Dominari Holdings Inc. | 4.63 Million USD | -9874.002% |
| Edesa Biotech, Inc. | 1.84 Million USD | -25002.395% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1463.551% |
| Bio-Techne Corporation | 744.34 Million USD | 37.892% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -266.613% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -34.21% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -1039.359% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1496.488% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -400.536% |
| Nkarta, Inc. | 105.6 Million USD | -337.779% |
| BioCardia, Inc. | 4.59 Million USD | -9971.786% |
| Iterum Therapeutics plc | 32.66 Million USD | -1315.391% |